View Older Stories View More Recent Stories

May 17, 2022 09:00AM VIPC’s Virginia Venture Partners Invests in Magazine Jukebox, Inc. to Provide Digital Alternative to Traditional Magazine Displays
May 17, 2022 07:00AM AviadoBio Presents Preclinical Data at ASGCT 2022 Demonstrating that AVB-101 Represents a Novel and Promising Approach to the Treatment of Frontotemporal Dementia
May 17, 2022 07:00AM AviadoBio Presents Preclinical Data at ASGCT 2022 Demonstrating that AVB-101 Represents a Novel and Promising Approach to the Treatment of Frontotemporal Dementia
May 16, 2022 04:05PM Lumos Pharma to Participate in Upcoming Investor Conferences
May 16, 2022 04:05PM Lumos Pharma to Participate in Upcoming Investor Conferences
May 16, 2022 04:00PM Celcuity Inc. Reports First Quarter 2022 Financial Results and Business Updates
May 16, 2022 09:00AM Timescale Announces OpenTelemetry Tracing Support for Promscale
May 16, 2022 07:03AM Celcuity (CELC) Announces $100M Private Placement
May 16, 2022 07:00AM Celcuity Inc. Announces $100 Million Private Placement
May 12, 2022 07:00AM AviadoBio Announces Formation of Scientific Advisory Board
May 12, 2022 02:00AM AviadoBio Announces Formation of Scientific Advisory Board  
May 10, 2022 04:01PM Lumos Pharma Reports First Quarter 2022 Financial Results and Clinical Development Updates
May 10, 2022 04:01PM Lumos Pharma Reports First Quarter 2022 Financial Results and Clinical Development Updates
May 5, 2022 04:08PM Form SC 13D/A Nkarta, Inc. Filed by: New Enterprise Associates 15, L.P.
May 5, 2022 04:05PM Form SC 13D/A Robinhood Markets, Inc. Filed by: New Enterprise Associates 15, L.P.
May 5, 2022 09:01AM Lumos Pharma, Inc. (LUMO) Enters Collaboration with Massachusetts General Hospital to Evaluate LUM-201
May 5, 2022 09:00AM Lumos Pharma Announces a Clinical Collaboration with Massachusetts General Hospital (MGH) to Evaluate Oral LUM-201 in Nonalcoholic Fatty Liver Disease (NAFLD) in a Phase 2 Investigator-Initiated Trial
May 5, 2022 09:00AM Lumos Pharma Announces a Clinical Collaboration with Massachusetts General Hospital (MGH) to Evaluate Oral LUM-201 in Nonalcoholic Fatty Liver Disease (NAFLD) in a Phase 2 Investigator-Initiated Trial
May 5, 2022 08:00AM Revelle Aesthetics Unveils New Minimally Invasive Procedure for Cellulite Reduction at Premier Aesthetic Plastic Surgery Conference
May 4, 2022 07:37PM Form 4 Robinhood Markets, Inc. For: May 02 Filed by: New Enterprise Associates 17, L.P.
May 4, 2022 09:00AM Sentry Raises $90 Million in Series E Funding to Expand and Drive Adoption of Developer-first Application Monitoring
May 4, 2022 08:00AM AviadoBio to Present Pre-clinical Data on its Gene Therapy Candidate for Frontotemporal Dementia at ASGCT 2022
May 3, 2022 07:30AM Pionyr Immunotherapeutics Adds Three Leading Oncology Researchers and Drug Developers to Scientific Advisory Board
Apr 27, 2022 07:00AM AviadoBio’s Gene Therapy Candidate Receives Orphan Designation from Food and Drug Administration and European Commission in Frontotemporal Dementia
Apr 27, 2022 02:00AM AviadoBio’s Gene Therapy Candidate Receives Orphan Designation from Food and Drug Administration and European Commission in Frontotemporal Dementia
Apr 26, 2022 09:00AM Lumos Pharma to Report First Quarter 2022 Financial Results and Host Conference Call on May 10, 2022
Apr 26, 2022 09:00AM Lumos Pharma to Report First Quarter 2022 Financial Results and Host Conference Call on May 10, 2022
Apr 26, 2022 08:46AM Slone Partners Places Richard B. Bartram as Chief Financial Officer at MBX Biosciences
Apr 25, 2022 05:07PM Form SC 13D/A IMARA Inc. Filed by: New Enterprise Associates 14, L.P.
Apr 25, 2022 05:05PM Form SC 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P.
Apr 22, 2022 02:38PM SOSV RELEASES CLIMATE TECH 100 LIST FOR 2022
Apr 20, 2022 12:00PM Wheelhouse Spins out of Lyric With $16 Million in Funding Led by Highgate Ventures and NEA to Strengthen Leadership Position in Accommodation & Rental Software
Apr 20, 2022 09:00AM VIPC’s Virginia Venture Partners Invests in Humanitru to Enhance Fundraising Efforts Conducted by Nonprofits
Apr 19, 2022 12:00PM Glacier Raises $4.5M to Combat Climate Change with AI-Powered Recycling Robots
Apr 12, 2022 01:14PM Multi-Camera 3D Vision Company NODAR Secures $12 Million in Funding from NEA
Apr 12, 2022 10:00AM New Web3 Learning Platform, Proof of Learn, Offers A New Approach to Accessible, High-Quality Education Across The Globe
Apr 12, 2022 10:00AM /C O R R E C T I O N -- Proof of Learn/
Apr 11, 2022 08:30AM Lumos Pharma Reaches 50% Randomization Milestone in Phase 2 OraGrowtH210 Trial Evaluating Oral LUM-201 in PGHD
Apr 11, 2022 08:30AM Lumos Pharma Reaches 50% Randomization Milestone in Phase 2 OraGrowtH210 Trial Evaluating Oral LUM-201 in PGHD
Apr 11, 2022 07:30AM MBX Biosciences Appoints Richard B. Bartram as Chief Financial Officer
Apr 7, 2022 10:00AM VIPC’s Virginia Venture Partners Investment in SCOUT Supports the First In-Space Observation Systems to Safeguard Orbital Infrastructure
Apr 7, 2022 08:06AM Trevi Therapeutics (TRVI) Announces $55 Million Private Placement of Common Stock, Warrants
Apr 7, 2022 08:00AM Claudia Fan Munce Joins Arteris IP Board of Directors
Apr 7, 2022 08:00AM Claudia Fan Munce Joins Arteris IP Board of Directors
Apr 7, 2022 08:00AM Trevi Therapeutics Announces $55 Million Private Placement Priced At-the-Market
Apr 6, 2022 10:17AM Gwyneth Paltrow, Cameron Diaz-backed Evernow raises $28.5 million
Apr 5, 2022 08:00AM MBX Biosciences Appoints Ora Hirsch Pescovitz, M.D., to Board of Directors
Apr 5, 2022 08:00AM Runway Growth Capital Announces a Senior Secured Term Loan of $25 Million to Revelle Aesthetics
Mar 23, 2022 04:05PM Lumos Pharma to Participate in the Cantor Rare Disease Symposium
Mar 23, 2022 04:05PM Lumos Pharma to Participate in the Cantor Rare Disease Symposium
View More Recent Stories View Older Stories